November 27, 2020
InSphero CEO Jan Lichtenberg extends holiday greetings from our teams in Switzerland and the United States, and looks back on the highlights of 2020: a tumultuous year shaped by a […]
November 26, 2020
InSphero Head of Operations David Fluri explains how our new award-winning InFloat™ shipping system helps make 3D in vitro cell technology more accessible to researchers worldwide. Did you know that […]
September 6, 2020
InSphero Scientist and islet biologist Joan Mir Coll discusses how multiparametic approaches for in vitro pancreatic research have the potential to revolutionize diabetes research. Over the past 3 decades, diabetes […]
July 2, 2020
InSphero has a rich history of collaborating with researchers at ETH Zürich. The most recent example is a joint effort to develop and apply a novel microfluidic perifusion system to […]
June 12, 2020
Microfluidics expert Olivier Frey explains how higher-order systems, such as multi-tissue Body-on-a-Chip networks, have the potential to faithfully replicate physiological interactions among different human organs–and what hurdles remain before this […]
May 1, 2020
InSphero recently had an opportunity to test the Yokogawa Platform for High Content Analysis (HCA) in our laboratories in Schlieren, Switzerland. Our goal was to see whether the Yokogawa instrument […]
May 1, 2020
An ongoing challenge in NASH Drug Discovery is selecting “fit for purpose” models for preclinical drug screening. InSphero liver expert Sue Grepper and Head of Liver Solutions Eva Thoma recently […]
March 13, 2020
As the coronavirus epidemic prompts cancellations of scientific meetings around the world, we have been working on alternative methods to keep you informed of advances in 3D cell-based assay technology, […]
February 26, 2020
InSphero Oncology Experts Francesca Chiovaro and Irina Agarkova often collaborate closely with academic and pharma partners who are developing therapeutics that target the innate immune system. In this blog, Francesca shares […]
December 18, 2019
InSphero CEO Jan Lichtenberg muses about how far 3D cell technology has come since InSphero was founded in 2009 and shares the latest news about how our disruptive 3D technology […]